M- PRIB -2 INJECTION

Name: M- PRIB -2 INJECTION
Brand: MEDICINE PLANET

Get a Price/Quote

MOQ : 5 Vials

M- PRIB -2 INJECTION Specification

Dosage Form
Injection, Lyophilized powder

Salt Composition
Bortezomib

Indication
Multiple Myeloma

Feature
Sterile single-use vial

Ingredients
Bortezomib 2mg

Application
Bolus Intravenous Injection

Physical Color/Texture
Lyophilized powder

Storage Instructions
Store below 25C, protected from light

Shelf Life
As per label, usually 18-24 months

Dose/Strength
2 mg

Sterile
Yes

Packaging Type
Vial

Form
Lyophilized

Color
White powder

Route
IP

Admin Route
IV bolus

Prescription Only
Yes

Reconstitution Needed
Yes

Pack Size
Vial

M- PRIB -2 INJECTION Trade Information

Minimum Order Quantity
5 Vials

Payment Terms
Cash in Advance (CID)

Supply Ability
100 Vials Per Month

Delivery Time
7 Days

Main Domestic Market
All India

About M- PRIB -2 INJECTION

Explore the exclusive M- PRIB -2 INJECTION, a top-drawer solution for patients diagnosed with multiple myeloma. This sterile, prescription-only injection contains 2 mg of Bortezomib in a perfectly formulated lyophilized powder, packaged in a single-use vial. The towering quality manufacturing processes assure safety, and it is to be reconstituted for intravenous bolus administration only. Add to Cart for a reliable treatment option manufactured and supplied directly from India. Store below 25C and protect from light for optimal shelf life.

Widespread Commercial and Clinical Use

M- PRIB -2 INJECTION is widely adopted across major hospitals and oncology centers for the management of multiple myeloma. It is suitable for adult patients requiring bolus intravenous injection and is designed for exclusive administration by healthcare professionals. Its application areas include oncology departments, specialty hospitals, and controlled clinical settings, offering trusted efficacy in cancer treatment protocols.

Reliable Supply, Global Certifications, and Seamless Delivery

As a certified exporter, manufacturer, and supplier, we guarantee a dependable supply of M- PRIB -2 INJECTION. We provide prompt quotations upon inquiry and follow a comprehensive sample policy for evaluation. Goods transport is efficiently managed, ensuring the product is delivered securely to your location. All shipments come with documentation authenticating international standards and quality certifications, making procurement smooth and reliable.

FAQ's of M- PRIB -2 INJECTION:

Q: How should M- PRIB -2 INJECTION be administered?

A: This medication is intended for intravenous bolus injection only and must be reconstituted prior to use by a qualified healthcare professional.

Q: What is the primary indication for using M- PRIB -2 INJECTION?

A: M- PRIB -2 INJECTION is primarily indicated for the treatment of multiple myeloma in adults.

Q: When is it necessary to store the vial below 25C?

A: The injection should always be stored below 25C and protected from light to maintain its effectiveness throughout its shelf life.

Q: Where is M- PRIB -2 INJECTION typically used?

A: It is mainly used in oncology clinics, hospitals, and specialized cancer treatment centers under medical supervision.

Q: What is the process for ordering and delivery?

A: Upon request, a quotation is provided, and after order confirmation, the goods are transported and delivered to the specified destination following quality and documentation checks.

Q: What are the key benefits of choosing M- PRIB -2 INJECTION?

A: Key benefits include its tailored formulation for myeloma, adherence to international safety standards, and reliable supply from certified manufacturers in India.